What is Emerge Diagnostics?
Founded in 2012 and headquartered in Carlsbad, California, Emerge Diagnostics is a global provider of medical services focused on the diagnosis and treatment of soft tissue injuries. The company's mission is to expedite patient recovery, enabling individuals to return to their work and daily lives more swiftly. Its operations span across global markets, offering specialized diagnostic and therapeutic solutions.
How much funding has Emerge Diagnostics raised?
Emerge Diagnostics has raised a total of $8.9M across 5 funding rounds:
Private Equity
$885K
Private Equity
$2.8M
Unspecified
$3M
Private Equity
$1.9M
Debt
$350K
Private Equity (2014): $885K, investors not publicly disclosed
Private Equity (2014): $2.8M, investors not publicly disclosed
Unspecified (2015): $3M supported by Undisclosed
Private Equity (2016): $1.9M, investors not publicly disclosed
Debt (2020): $350K backed by PPP
What's next for Emerge Diagnostics?
The recent major strategic investment signifies a pivotal moment for Emerge Diagnostics, likely enabling the company to further scale its operations, enhance its diagnostic technologies, and expand its service reach. This capital infusion is expected to fuel innovation and solidify its position in the competitive medical services landscape, potentially leading to new treatment protocols and broader market penetration.
See full Emerge Diagnostics company page
